Article info
PDFOriginal research
Why we should stop using animal-derived products on patients without their consent
- Correspondence to Daniel Rodger, Institute of Health and Social Care, London South Bank University, School of Allied and Community Health, London SE1 0AA, UK; daniel.rodger{at}lsbu.ac.uk
Citation
Why we should stop using animal-derived products on patients without their consent
Publication history
- Received March 1, 2021
- Accepted May 14, 2021
- First published June 8, 2021.
Online issue publication
September 28, 2022
Article Versions
- Previous version (8 June 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Implications of religious and cultural beliefs on selection of medicines
- Medical ethics for children: applying the four principles to paediatrics
- Consent for anaesthesia
- In defence of personal autonomy
- Ethics of care challenge to advance directives for dementia patients
- Informed consent should be obtained from patients to use products (skin substitutes) and dressings containing biological material
- Respect for autonomy: deciding what is good for oneself
- Ethical and practical considerations in prescribing animal-derived medication
- Ethics needs principles—four can encompass the rest—and respect for autonomy should be “first among equals”
- Does the General Medical Council’s 2020 guidance on consent advance on its 2008 guidance?